MedWatch

Companies fail one after the other: Why the Alzheimer’s mystery remains unsolved

One drug group after the other has burned its fingers in the attempt to develop treatments against Alzheimer’s Disease. Since year 2000, only one new therapy has entered the market. But why is Alzheimer’s such a tough nut to crack?

Photo: /ritzau/Asger Ladefoged

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Ny liste: Novo-toppen blandt de mest magtfulde i Danmark

Toppen af dansk magtelite er spækket med Novo-bosser, der indtager seks ud af 100 pladser over de mest magtfulde personer i Danmark i 2018, viser ny magtanalyse, der også afslører, at det Novo-koncernen undtaget er sparsomt med islæt fra dansk life science – én anden medico-boss har dog sneget sig med blandt de 100 med mest magt.

Related articles